Research

Our UCNI Neurocritical Care physicians play an important role in brain injury research and the establishment of evidence-based treatment guidelines for traumatic brain injury.

Current clinical trials

Spreading Depressions as Secondary Insults after Traumatic Injury to the Human Brain
Funded by: Department of Defense
Principal Investigator: Jed Hartings, PhD
 

PTSD/TBI Clinical Consortium Study Site Award
Funded by: Department of Defense
Principal Investigator: Lori Shutter, MD
 

Point of Care – Care Center for Emerging Neurotechnologies
Funded by: National Institutes of Health
Principal Investigators: Fred Beyette, PhD, and Joe Clark, PhD
 

Neurological Emergencies Treatment Trials (NETT) Network: The Greater Cincinnati / Northern Kentucky NETT Network Hub and Spoke System
Funded by: National Institutes of Health (NINDS)
Principal Investigator: Arthur Pancioli, MD
 

ProTECT III: Progesterone for Traumatic Brain Injury: Experimental Clinical Treatment
Funded by: National Institutes of Health (NINDS)
Principal Investigator: Arthur Pancioli, MD
 

Reducing Secondary Insults in Traumatic Brain Injury
Funded by: Department of Defense/Air Force District of Washington
Principal Investigator: Jay Johannigman, MD
 

CLEAR III Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Funded by: National Institutes of Health
Principal Investigator: Opeolu Adeoye, MD
 

CONSCIOUS III: A prospective, multi-center, double-blind, randomized, placebo-controlled,parallel-group study to assess the efficacy and safety of clazosentan in reducing vasospasm-related morbidity and all-cause mortality in adult patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling.
Funded by: Actelion
Principal Investigator: Andrew Ringer, MD
 

ICH Removal: Safety and Efficacy of Minimally Invasive Surgery + rtPA 
Funded by: NINDS/ Genentech
Principal Investigator: Mario Zuccarello, MD
 

Pilot Study of NSICU Assessment of Seizure Prophylaxis with Lacosamide (LCM)
Funded by: UCB Pharma Inc.
Principal Investigator: Jerzy Szaflarski, MD, PhD